INTRODUCTION
Enterotoxigenic Escherichia coli (ETEC) is the cause of diarrheal diseases leading to several hundred million cases of diarrhea and several ten of thousand deaths annually [1] . The diarrhea is mainly due to the action of enterotoxins released from the bacteria. ETEC produces both heat-stable and heat-labile (LTs) enterotoxins. The LTs belong to AB 5 toxins, a family of oligomeric proteins consisting of an A-subunit with catalytic activity and a pentameric B-subunit responsible for the binding to host glycoconjugates [2, 3] . ETEC enterotoxins together with cholera toxin (CT) constitute one of the four subgroups of AB 5 toxins [3] .
The family of ETEC enterotoxins is divided into type I and type II, where the type I Bsubunits are most related to the CT B-subunits. There are three members of the ETEC type II heat-labile enterotoxins: LT-IIa, LT-IIb, and LT-IIc. The amino acid sequences of these Asubunits have only approximately 50-60% identity with the A-subunits of CT/LT type I, and there is no amino acid homology between the type II B-subunits and CT/LT type I B-subunits [4] .
LTs and CT receptors are mainly gangliosides, a subclass of glycosphingolipids containing one or several sialic acid residues. Glycosphingolipids are classified on the basis of their carbohydrate core structures. In humans the lacto/type 1 (Galβ3GlcNAc), neolacto/type 2 (Galβ4GlcNAc), and globo/type 4 (Galα4Gal) core chains are the most common in non-acid glycosphingolipids, while gangliosides are mainly based on ganglio (Galβ3GalNAc) or neolacto core chains. The primary receptor of B-subunits of CT and LT type I is the GM1 ganglioside [5] , although LT type I also binds to glycoconjugates with terminal N-acetyllactosamine [6, 7] . Binding of type II enterotoxin B-subunits have hitherto only been tested on gangliosides with ganglio core chain, demonstrating that LT-IIa binds to a range of such gangliosides, with highest affinity for the GD1b ganglioside, while LT-IIb interacts preferentially with gangliosides GD1a and GT1b [8, 9] . The gangliosides recognized by LT-IIc are GM1, GM2, GM3 and GD1a [10] , with a preference for GM1 with long fatty acyl ceramide chain [9] .
While a large amount of CT and LT type 1 structures bound to a variety of glycan receptors are available [11] [12] [13] [14] , the structural data on LT-IIb is limited [4, 15] . The overall structure of the LT-IIb holotoxin [4] closely resembles that of CT. Despite of the very limited sequence identity, the B-subunit of LT-IIb adopts a very similar fold as the B-subunits of CT and LT type 1. The putative ganglioside binding site of LT-IIb was proposed to be located in the same region as the GM1 binding sites of CT and LT type I [4] .
In the present work, we further investigated the carbohydrate binding specificity of LT-IIb using our unique collection of gangliosides of various core chain series from different sources [16] , and also a number of related non-acid glycosphingolipids. We also determined the first crystal structure of the B-subunit of LT-IIb with a ligand bound, namely with the pentasaccharide moiety of NeuAcα3-neolactotetraosylceramide (NeuAc-nLT:
NeuAcα3Galβ4GlcNAcβ3Galβ4Glc) establishing the molecular basis of the specificity and demonstrating the differences with the binding sites of LT-I/CT B-subunits.
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EXPERIMENTAL PROCEDURES
Production of recombinant LT-IIb B-subunits
Recombinant LT-IIb B-subunits was produced from a synthetic gene purchased from ATG- the experimental values and all curves were integrated according to the previously described protocol [17] .
Radiolabeling
Aliquots of 100 μg of B-subunits were labeled with 125 I, using Na 125 I (100 μCi/ml;
Amersham Pharmacia Biotech, Little Chalfont, U.K.), according to the IODO-GEN protocol of the manufacturer (Pierce, Rockford, IL), giving approximately 5 x 10 3 cpm/μg protein.
Reference glycosphingolipids
Total acid and neutral glycosphingolipid fractions were obtained by standard procedures [18] .
The individual glycosphingolipids were isolated by repeated chromatography on silicic acid columns of the native glycosphingolipid fractions, or acetylated derivatives thereof. The identity of the purified glycosphingolipids was confirmed by mass spectrometry [19, 20] and proton NMR spectroscopy [21] .
Thin-layer chromatography
Precoated silica gel 60 HPTLC plates with either a glass or aluminium support (Merck, Darmstadt, Germany) were used for thin-layer chromatography. The solvent system used for separation of glycosphingolipids was chloroform/methanol/water 60:35:8 (by volume).
Glycosphingolipids were detected by the anisaldehyde reagent [22] or the resorcinol reagent [23] .
Chromatogram binding assay
Binding of radiolabeled LT-IIb B-subunits to glycosphingolipids separated on thin-layer chromatograms was performed as described [7] . In short, 20 -40 μg of mixtures of glycosphingolipids, or 20 ng -4 μg of pure compounds, were separated on aluminium-backed thin-layer plates. Dried chromatograms were dipped for 1 min in diethylether/n-hexane (1:5, by volume) containing 0.5% (w/v) polyisobutylmethacrylate (Aldrich Chem. Comp. Inc., Milwaukee, WI). After drying, the chromatograms were soaked in PBS, containing 2% bovine serum albumin and 0.1% NaN 3 (BSA/PBS), for 2 h at RT. Thereafter the plates were incubated with 125 I-labeled B-subunits diluted in BSA/PBS (1-2 x 10 6 cpm/ml) for another 2 h at RT. After washing six times with PBS, and drying, the thin-layer plates were autoradiographed for 12 h using XAR-5 x-ray films (Eastman Kodak, Rochester, NY).
Isolation of human small intestinal gangliosides recognized by LT-IIb B-subunits
One total acid glycosphingolipid fraction from human small intestine (675 mg) was separated by repeated silicic acid chromatography, and followed by repeated chromatography on Manual assignment of glycosphingolipid sequences was done with the assistance of the Glycoworkbench tool (Version 2.1), and by comparison of retention times and MS 2 spectra of reference glycosphingolipids.
Crystallization and data collection
A solution of LT-IIb B-subunit (10 mg ml -1 ) in sodium carbonate 50 mM pH 9 was sent to the Diffraction data for the LT-IIb/NeuAc-nLT complex was collected to 1.72 Å on ID23-2 beamline using a Pilatus detector at the ESRF, Grenoble. Diffraction images were integrated using XDS program [24] , and all further processing done using the CCP4 program suite [25] .
Structure determination and refinement
The structure was solved by molecular replacement with PHASER [26] using the coordinates from the B-pentamer of the LT-IIb structure (PDB ID 1TII) as search model. The initial model was optimized using ARP/wARP [27] prior restrained maximum likelihood refinement with REFMAC 5.8 [28] iterated with manual rebuilding in Coot [29] . Five percent of the observations were set aside for cross-validation analysis, and hydrogen atoms were added in their riding positions and used for geometry and structure-factor calculations. Incorporation of the ligand was performed after inspection of the 2F o -F c weighted maps. Water molecules, introduced automatically using Coot, were inspected manually. The quality of the models was assessed using the PDB validation server (http://wwpdb-validation.wwpdb.org/validservice/) and coordinates were deposited in the Protein Data Bank under code 5G3L.
RESULTS
Recombinant expression and purification of LT-IIb B-subunits
The LT-IIb B-subunit was isolated in high yield, i.e. 30 mg of protein was obtained from 2 L culture medium. The purified protein migrated as a single band, and the apparent molecular weight of the monomeric protein was in agreement with the predicted molecular mass of 11.8 kDa ( Figure S1 in Suppl. Mat., lanes 3-5). The pentameric form of the LT-IIb Bsubunit appears to run at a molecular weight of approximately 50 kDa in agreement with the predicted molecular mass ( Figure S1 in Suppl. Mat., lanes 7-9). The protein was stable in several of the solvents tested, allowing us to store it in the refrigerator at 4 ºC for weeks, without seeing a change in its activity. The protein thermostability and its buffer preference was determined using thermal shift assays, showing the highest T m , of 77 ºC in HEPES buffer pH 8.5 with 20 mM NaCl ( Figure S2 in Suppl. Mat.). 
Binding of LT-IIb B-subunits to mixtures of gangliosides
Binding of LT-IIb B-subunits to reference gangliosides
Next, the binding of radiolabeled LT-IIb B-subunits to a collection of variant gangliosides [18] was examined (Figure 2 and Figures S3 and S4 in Suppl. Mat.). The results of the binding assays are summarized in Table 1 ). As reported previously [8, 9] the B-subunits bound to the GD1a ganglioside, while no binding to the GD1b or GT1b gangliosides was obtained.
In addition, the B-subunits of LT-IIb bound to a number of gangliosides with neolacto core, 
Binding of LT-IIb B-subunits to dilutions of gangliosides
Dilutions of gangliosides on thin-layer chromatograms were used for estimation of the relative binding affinities of LT-IIb for the binding active gangliosides. Here. NeuGcα3neolactohexaosylceramide was the preferred ligand with a detection limit at less than 20 ng ( Figure S5B, lane 10) , while the detection limits for NeuAcα3-neolactotetraosylceramide and the GD1a ganglioside were approximately 800 ng ( Figure S5A, lane 3) .
Human small intestinal ganglioside recognized by LT-IIb B-subunits
The slow-migrating LT-IIb B-subunit binding ganglioside of human small intestine was isolated by repeated chromatographies on silicic acid and Iatrobeads columns, and the preparative procedure was monitored by binding of radiolabeled LT-IIb B-subunits on thinlayer chromatograms. Finally, two LT-IIb binding fractions were obtained and designated fractions A-1 and A-2 ( Figure 3B, lanes 1 and 2) , while the following non-binding fractions were designated A-3 and A-4 ( Figure 3B, lanes 3 and 4) .
LC-ESI/MS of the human small intestinal ganglioside recognized by LT-IIb B-subunits
The 
Crystal structure of LT-IIb in complex with Sialyl-lacto-N-tetraose
LT-IIb B-subunit gave crystals between one day to one week with either needle or parallelipipedic morphology, under different conditions (see Supplementary Table S1 ). In a second step, crystals of LT-IIb B-subunits were optimized manually using 20% peg 3350, 0.2M KCl and 0.1 M buffer pH 6.0-7.6 and the protein was co-crystallized with NeuAc-nLT Data were collected at 1.72 Å resolution and indexed in the orthorhombic space group 
DISCUSSION AND CONCLUSION
In this study, we have expressed a recombinant LT-IIb B-subunit and investigated the carbohydrate binding specificity by means of solid phase glycosphingolipid binding studies.
By binding to a variety of glycosphingolipids separated on thin-layer chromatograms, we found that LT-IIb B-subunits bind with high affinity to gangliosides with neolacto core chain as e.g. NeuGcα3-and NeuAcα3-neolactohexa-and neolactooctaosylceramide. Previous studies of the carbohydrate recognition by LT-IIb were done using a limited number of gangliosides with ganglio core chain, which explains why the LT-IIb binding to neolacto based gangliosides was overlooked. Furthermore, by isolating LT-IIb binding gangliosides from human small intestine, we established the link between the NeuAc-neolacto gangliosides presence on the target tissue and the LT-IIb infection of intestinal cells, where the protein recognition of these antigens promotes the initial steps of the disease.
Lymphocytes are also target cells of LT-IIb, since this protein is a potent adjuvant.
Interestingly, the immune responses induced by LT-IIa and LT-IIb are distinctive from those induced by CT or LT-I [37] . While CT and LT-I induce Th2 responses to co-administered antigens, LT-IIa and LT-IIb give a more balanced Th1/Th2 response. These differences have been attributed to the binding of the B-subunits to different ganglioside receptors on lymphocytes [38] . The available data about human lymphocyte gangliosides structures is very limited. However, NeuAc-GM3 is the major ganglioside of both peripheral blood lymphocytes and monocytes, and these cells also have NeuAc-neolactotetraosylceramide [39, 40] . Thus, the identified NeuAcα3-neolacto binding of LT-IIb may also have a role in the immunomodulatory activities of the protein. A secondary binding site with affinity for blood group determinants has been identified on the side of the β-barrel of CT and LT-I B-subunits [14, 42] . However, a secondary binding site in the vicinity of the primary site, and accommodating the same ligand, has not previously been found in the B-subunits of V. cholerae or ETEC. In this respect LT-IIb resembles the Shigalike toxins from E. coli where there are three carbohydrate binding sites in each B-subunit, providing an increased binding affinity to the globotriasylceramide receptor [43, 44] .
However, at the present time, it is not clear if the secondary binding site could accommodate the second NeuAc of a divalent ligand such as GD1a or if it would bind to different sialylated glycolipids on cell surfaces. Our attempts to fit the two NeuAc residues of a single GD1a oligosaccharides in the two sites were not successful, so the second hypothesis seems to be more likely. Table 1 . NeuAcα3GalNAcβ3Galα4Galβ4Glcβ1Cer -Human embryonic stem cells c a) Binding is defined as follows: +++ denotes an intense and highly reproducible staining when 4 μg of the glycosphingolipid was applied on the thin-layer chromatogram, + denotes an occasional staining, while -denotes no binding even at 4 μg. b) The NeuAc/NeuGcα3Galβ4GlcNAc and NeuAcα3Galβ3GalNAc sequences are underlined. c) Binding of LT-IIb to compounds 16 and 40 was evaluated using the slow-migrating ganglioside fraction from human embryonic stem cells (fraction 181C) [45] . Two inflections are seen. The first regards the pentamer dissociation (around 46 ºC) while the second represents the monomer unfolding, which takes place at higher temperatures. A small T m variation (72 -77 ºC) is seen in these tested conditions. The data for the protein in water pH 7.3 solution is shown in a light blue color; water + 20mM NaCl, in dark blue; HEPES pH 8.5, in pink; and HEPES + 20mM NaCl, in grey. Figure S3 . .
Glycosphingolipid binding of LT-IIb B-subunits
SUPPLEMENTARY MATERIAL
Biochemical and structural characterization of the novel sialic acid-binding site of Escherichia coli heat-labile enterotoxin LT-IIb
